Enbio KRX:352940KOSDAQ

인바이오 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days2
Articles tracked8since Sep 11

In Q3 2026, Enbio reported revenue of ₩4.2bn, up 7.5% year on year, and an operating loss of ₩1.9bn. Enbio (인바이오) appeared in 0 Korean news articles and 2 DART filings over the past seven days.

Filing signals Insider buying Dilution risk Screener

Enbio at a glance from DART filings

Results trend
Operating profit in 2 of the last 4 quarters; Q3 2026 operating loss of ₩1.9bn swung to a loss from a profit in the previous quarter.
Ownership changes
9 5%-holder and insider ownership reports in the past 120 days (9 increases, 0 decreases).
Capital & buybacks
Decisions in the past year: convertible bonds ×1.

Figures the company filed on DART, grouped by ATS View. Not a buy or sell call; see the cards below and the DART originals.

Enbio today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

Dates Enbio stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Enbio quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩4.2bn+7.5%−₩1.9bn
margin −45.5%
−₩1.5bn
Q2 2026₩10.4bn+22.5%₩172m
margin 1.6%
−₩41m
Q1 2026₩14.1bn+2.2%₩3.1bn
margin 22.1%
₩2.2bn
Q4 2025 derived₩7.7bn+48.3%−₩729m
margin −9.5%
−₩482m
Q3 2025₩3.9bn-34.8%−₩1.3bn
margin −34.1%
−₩1.1bn
Q2 2025₩8.5bn-3.5%−₩167m
margin −2.0%
₩182m
Q1 2025₩13.8bn-11.4%₩3.2bn
margin 22.8%
₩2.4bn
Q4 2024 derived₩5.2bn+13.6%−₩2.2bn
margin −42.2%
−₩1.8bn

Enbio ranks #1955 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Enbio top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Enbio news Korean headlines